Skip to main contentAll people

GRZEGORZ BULAJ

Associate Professor

Medicinal Chemistry

  • Associate Professor
    Medicinal Chemistry
  • Adjunct Assistant Professor
    Anesthesiology
  • 801-581-4629 (Work)

RESEARCH INTERESTS

The long-term goal of our research is to integrate digital therapeutics (DTx, mobile medical apps) with pharmaceutical drugs and biologics. Since mobile apps and video games have become the FDA-authorized “software as medical device” products, they can be combined with drug-based therapies by means of adjunct DTx or drug-device combination products. You can learn more about our approach to improve treatments of chronic diseases from our J Clin Med 2024 article, link: https://www.mdpi.com/2077-0383/13/2/403.

Why digital health technologies? Because:

  1. They can mitigate limitations of pharmaceutical drugs (adverse effects, non-adherence, drug-resistance, affordability, shortages)
  2. Mobile app-based treatments can improve sustainability of health care by delivering self-management and empowerment, while promoting prevention of chronic conditions.
  3. The health care outcomes in the US are the worst among high-income countries despite the highest health care spending per capita in the world.
 

 

GRANTS

  • EXTERNAL GRANT OR CONTRACT
    ANALGESIC GALANIN ANALOGS
    UNIVERSITY OF WASHINGTON1 Jun 2016 - 31 Dec 2020
    UNIVERSITY OF WASHINGTON
  • EXTERNAL GRANT OR CONTRACT
    GALANIN ANALOGS FOR PAIN - BUL
    ARMY MEDICAL RESEARCH ACQUISIT1 Jan 2015 - 1 May 2016
    ARMY MEDICAL RESEARCH ACQUISIT
  • EXTERNAL GRANT OR CONTRACT
    UOFUTAH-JJPRD PEPTIDE COLLABOR
    J&J PHARMACEUTICAL RSRCH & DEV1 Jan 2010 - 31 Dec 2012
    J&J PHARMACEUTICAL RSRCH & DEV
  • EXTERNAL GRANT OR CONTRACT
    Systemically-Active Galanin Analogs
    NIH NATL INST NEUROLOG DISORDE7 Jan 2008 - 31 Jul 2010
    NIH NATL INST NEUROLOG DISORDE
  • EXTERNAL GRANT OR CONTRACT
    Conus Peptides and Their Receptor Targets
    NIH NATIONAL INST OF GENERAL M2 Jan 2008 - 31 Dec 2011
    NIH NATIONAL INST OF GENERAL M
  • EXTERNAL GRANT OR CONTRACT
    Labeling Neuropeptides
    NEUROADJUVANTS INC1 Jan 2007 - 31 Dec 2008
    NEUROADJUVANTS INC
  • EXTERNAL GRANT OR CONTRACT
    REFRACTORY EPILEPSY
    EPILEPSY FOUNDATION1 Jan 2007 - 31 Dec 2007
    EPILEPSY FOUNDATION
  • EXTERNAL GRANT OR CONTRACT
    Sodium Channel Contratoxins Derived from Cone Snail Venoms
    NIH NATL INST NEUROLOG DISORDE6 Jan 2006 - 31 May 2009
    NIH NATL INST NEUROLOG DISORDE
  • EXTERNAL GRANT OR CONTRACT
    CONOTOXIN: FOLDING
    COGNETIX INC1 Jan 2000 - 31 Dec 2000
    COGNETIX INC